Gilead Sciences Inc.

Will Obesity Drugs Break the Healthcare System?

9:16 a.m. Sept. 21, 2023

- Josh Nathan-Kazis

Kroger, Apple, Planet Labs, Smartsheet, RH, Snowflake, and More Stock Market Movers

4:15 p.m. Sept. 8, 2023

- Joe Woelfel

Gilead Stock Looks Underappreciated and Oversold, Say BofA Analysts

11:20 a.m. Sept. 8, 2023

- Emily Dattilo

Stock buybacks spur wealth inequality and stifle innovation. Should they be banned?

9:44 a.m. Aug. 26, 2023

- Ciara Linnane

Nvidia stock rises ahead of results, Foot Locker and Peloton tank, and other stocks on the move

11:57 a.m. Aug. 23, 2023

- MarketWatch

Gilead, Arcus, iTeos, other biopharmas get boost from accidental disclosure of Roche lung cancer trial data

8:45 a.m. Aug. 23, 2023

- Eleanor Laise

Gilead says FDA hits pause on study of leukemia treatment

8:47 a.m. Aug. 21, 2023

- Eleanor Laise

Amazon shares rally 10%, but Apple’s dip, and other stocks on the move

2:17 p.m. Aug. 4, 2023

- MarketWatch

Gilead’s profit lags consensus but sales beat, sending stock up after hours

8:06 p.m. Aug. 3, 2023

- Ciara Linnane

Gilead Sciences Cuts Profit Forecast on Legal Settlement

4:43 p.m. Aug. 3, 2023

- Josh Nathan-Kazis

Gilead’s stock slides 2% after Q2 profit lags consensus and as company lowers guidance

4:15 p.m. Aug. 3, 2023

- Ciara Linnane

Gilead Sciences’ stock slides 3.4% in after-hours trade

4:07 p.m. Aug. 3, 2023

- Ciara Linnane

Gilead Sciences now sees full-year product sales of $26.3 bln to $26.7 bln vs. prior guidance of $26.0 bln to $26.5 bln

4:06 p.m. Aug. 3, 2023

- Ciara Linnane

Gilead Sciences now sees full-year adj. EPS of 6.45 to $6.80 vs. $6.60 to $7.00 previously

4:05 p.m. Aug. 3, 2023

- Ciara Linnane

Gilead Sciences Q2 revenue up 5% to $6.6 bln; FactSet consensus $6.5 bln

4:04 p.m. Aug. 3, 2023

- Ciara Linnane

Gilead Sciences Q2 EPS 83 cents vs. 91 cents a year ago

4:03 p.m. Aug. 3, 2023

- Ciara Linnane

Gilead Sciences Q2 adj. EPS $1.34; FactSet consensus $1.64

4:03 p.m. Aug. 3, 2023

- Ciara Linnane

Earnings Galore, the Jobs Report, and More to Watch

9:25 a.m. July 31, 2023

- Nicholas Jasinski

Stocks Poised to Open Higher

6:37 p.m. July 30, 2023

- Janet H. Cho

With Hurricane Season Looming, Florida Faces an Insurance Meltdown

8:02 p.m. July 28, 2023

- Andrew Welsch

This Cancer Therapy is Lifesaving, but There Isn’t Enough of It

2:33 a.m. Sept. 22, 2023

- The Wall Street Journal Interactive Edition

The Brash Strategy That Made Vivek Ramaswamy a Fortune

8:01 a.m. Sept. 18, 2023

- The Wall Street Journal Interactive Edition

Gilead Sciences Is the Target of a Bizarre Legal Theory

10:34 a.m. Aug. 20, 2023

- The Wall Street Journal Interactive Edition

Gilead Sciences Defeats the CDC

2:34 a.m. May 11, 2023

- The Wall Street Journal Interactive Edition

10-Q: GILEAD SCIENCES, INC.

4:10 p.m. May 3, 2023

- Edgar Online - (EDG = 10Q, 10K)

These Drugs Are So Futuristic That Doctors Need New Training

2:32 a.m. April 13, 2023

- The Wall Street Journal Interactive Edition

Higher Rates Are Coming for U.S. Companies

2:34 a.m. March 29, 2023

- The Wall Street Journal Interactive Edition

First Drugs Facing Medicare Price Penalty Are Named

3:57 a.m. March 16, 2023

- The Wall Street Journal Interactive Edition

Seagen’s Cancer Therapy Is Making It a Takeover Target

8:44 a.m. June 5, 2023

- The Wall Street Journal Interactive Edition

10-K: GILEAD SCIENCES, INC.

5:30 p.m. Feb. 22, 2023

- Edgar Online - (EDG = 10Q, 10K)

John Rogers' Firm Enters Carlyle Group Stake, Powers Up Generac Position

4:54 p.m. Feb. 22, 2023

- GuruFocus.com

AQR CAPITAL MANAGEMENT LLC Buys 3, Sells 2 in 4th Quarter

11:00 p.m. Feb. 17, 2023

- GuruFocus.com

VALUEWORKS LLC Buys 1, Sells 4 in 4th Quarter

9:00 p.m. Feb. 17, 2023

- GuruFocus.com

Top 5 4th Quarter Trades of HealthInvest Partners AB

7:00 p.m. Feb. 17, 2023

- GuruFocus.com

Top 5 4th Quarter Trades of Nan Shan Life Insurance Co., Ltd.

3:00 p.m. Feb. 16, 2023

- GuruFocus.com

Top 5 4th Quarter Trades of Avalon Investment & Advisory

3:00 a.m. Feb. 15, 2023

- GuruFocus.com

Caxton Associates Buys 4, Sells 1 in 4th Quarter

7:00 p.m. Feb. 14, 2023

- GuruFocus.com

John Rogers Buys 3, Sells 2 in 4th Quarter

11:00 a.m. Feb. 14, 2023

- GuruFocus.com

GLOBEFLEX CAPITAL L P Buys 4, Sells 1 in 4th Quarter

5:00 p.m. Feb. 12, 2023

- GuruFocus.com

Top 5 4th Quarter Trades of KLCM Advisors, Inc.

5:00 p.m. Feb. 12, 2023

- GuruFocus.com